Eli Lilly and Company, UnitedHealth Group, Hims & Hers Health, Becton, Dickinson and Company, Walmart, Stryker, and Abbott Laboratories are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies involved in the healthcare sector, including pharmaceutical manufacturers, biotechnology firms, medical device makers and healthcare service providers. Investors buy and sell these stocks to gain exposure to the industry’s growth potential, research breakthroughs and demographic-driven demand for medical services. Their performance is often influenced by regulatory approvals, clinical trial results and broader economic conditions. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
LLY traded up $31.00 during trading on Friday, hitting $825.10. 6,056,616 shares of the company's stock were exchanged, compared to its average volume of 3,482,067. Eli Lilly and Company has a 1 year low of $677.09 and a 1 year high of $972.53. The stock has a 50 day moving average price of $825.36 and a 200 day moving average price of $816.37. The firm has a market cap of $782.34 billion, a P/E ratio of 70.46, a price-to-earnings-growth ratio of 1.40 and a beta of 0.51. The company has a current ratio of 1.15, a quick ratio of 0.97 and a debt-to-equity ratio of 2.00.
Read Our Latest Research Report on LLY
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
NYSE UNH traded down $1.96 during trading hours on Friday, hitting $398.72. The company had a trading volume of 11,384,114 shares, compared to its average volume of 4,602,582. The firm's 50 day moving average is $495.85 and its 200 day moving average is $528.74. The company has a market capitalization of $362.92 billion, a price-to-earnings ratio of 25.72, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group has a fifty-two week low of $393.11 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.
Read Our Latest Research Report on UNH
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Shares of NYSE:HIMS traded up $4.82 during mid-day trading on Friday, hitting $40.98. 49,512,288 shares of the company traded hands, compared to its average volume of 16,783,776. The firm's 50 day simple moving average is $32.21 and its 200 day simple moving average is $31.43. The firm has a market cap of $9.10 billion, a P/E ratio of 93.14 and a beta of 1.65. Hims & Hers Health has a 52-week low of $11.20 and a 52-week high of $72.98.
Read Our Latest Research Report on HIMS
Becton, Dickinson and Company (BDX)
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.
NYSE:BDX traded down $0.93 during trading hours on Friday, hitting $168.61. The stock had a trading volume of 10,519,115 shares, compared to its average volume of 1,809,744. The company has a market cap of $48.41 billion, a PE ratio of 28.01, a price-to-earnings-growth ratio of 1.63 and a beta of 0.35. The business has a 50 day simple moving average of $214.76 and a two-hundred day simple moving average of $225.70. Becton, Dickinson and Company has a 1-year low of $166.11 and a 1-year high of $251.99. The company has a current ratio of 1.13, a quick ratio of 0.63 and a debt-to-equity ratio of 0.69.
Read Our Latest Research Report on BDX
Walmart (WMT)
Walmart Inc. engages in the operation of retail, wholesale, other units, and eCommerce worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores under Walmart and Walmart Neighborhood Market brands; membership-only warehouse clubs; ecommerce websites, such as walmart.com.mx, walmart.ca, flipkart.com, PhonePe and other sites; and mobile commerce applications.
Shares of NYSE WMT traded up $1.32 during trading on Friday, reaching $98.73. 16,026,369 shares of the stock were exchanged, compared to its average volume of 17,836,499. The business's 50-day moving average price is $90.52 and its 200 day moving average price is $91.33. The company has a market capitalization of $789.93 billion, a price-to-earnings ratio of 40.97, a price-to-earnings-growth ratio of 4.42 and a beta of 0.69. Walmart has a twelve month low of $59.14 and a twelve month high of $105.30. The company has a quick ratio of 0.23, a current ratio of 0.82 and a debt-to-equity ratio of 0.40.
Read Our Latest Research Report on WMT
Stryker (SYK)
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
SYK stock traded up $4.61 during trading on Friday, reaching $378.60. The stock had a trading volume of 3,709,100 shares, compared to its average volume of 1,356,830. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 0.59. The firm has a fifty day moving average price of $366.38 and a 200 day moving average price of $373.73. The company has a market capitalization of $144.51 billion, a P/E ratio of 48.79, a PEG ratio of 2.93 and a beta of 0.93. Stryker has a 1-year low of $314.93 and a 1-year high of $406.19.
Read Our Latest Research Report on SYK
Abbott Laboratories (ABT)
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.
Shares of NYSE ABT traded up $2.04 during midday trading on Friday, reaching $132.92. 9,801,356 shares of the company's stock were exchanged, compared to its average volume of 6,117,118. The stock has a market capitalization of $230.53 billion, a PE ratio of 17.38, a price-to-earnings-growth ratio of 2.52 and a beta of 0.80. Abbott Laboratories has a 52-week low of $99.71 and a 52-week high of $141.23. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.14 and a current ratio of 1.60. The business's fifty day moving average price is $130.21 and its two-hundred day moving average price is $122.92.
Read Our Latest Research Report on ABT
Featured Articles
Before you consider Eli Lilly and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.
While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
